Cargando…

What can we learn from drug marketing efficiency?

The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies’ techniques could be used to improve safety surveillance systems

Detalles Bibliográficos
Autor principal: Kao, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230247/
https://www.ncbi.nlm.nih.gov/pubmed/19050331
http://dx.doi.org/10.1136/bmj.a2591
_version_ 1782218047040258048
author Kao, David P
author_facet Kao, David P
author_sort Kao, David P
collection PubMed
description The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies’ techniques could be used to improve safety surveillance systems
format Online
Article
Text
id pubmed-3230247
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-32302472011-12-06 What can we learn from drug marketing efficiency? Kao, David P BMJ Analysis The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies’ techniques could be used to improve safety surveillance systems BMJ Publishing Group Ltd. 2008-12-02 /pmc/articles/PMC3230247/ /pubmed/19050331 http://dx.doi.org/10.1136/bmj.a2591 Text en © BMJ Publishing Group Ltd 2008
spellingShingle Analysis
Kao, David P
What can we learn from drug marketing efficiency?
title What can we learn from drug marketing efficiency?
title_full What can we learn from drug marketing efficiency?
title_fullStr What can we learn from drug marketing efficiency?
title_full_unstemmed What can we learn from drug marketing efficiency?
title_short What can we learn from drug marketing efficiency?
title_sort what can we learn from drug marketing efficiency?
topic Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230247/
https://www.ncbi.nlm.nih.gov/pubmed/19050331
http://dx.doi.org/10.1136/bmj.a2591
work_keys_str_mv AT kaodavidp whatcanwelearnfromdrugmarketingefficiency